different types of glp-1 Indications for GLP-1/GIP RA Summary Sheet and Beyond! GLP-1 Drug Savings: A Complete

Kreider RB, et al

Research shows that both aerobic and resistance exercises, performed at moderate to high intensity, can increase GLP-1 levels

Phase III results for retatrutide are set to be released later in 2025 and in early 2026, but an earlier phase II trial recorded between a 7.2% and 17.5% reduction in body weight after 24 weeks, depending on the dose (7.2% on 1mg, 17.5% on 12mg), and up to a 24.2% reduction in body weight after 48 weeks for those on 12mg (-8.7% change for those on 1mg) 8

GremlichSPorretAHaniEHCherifDVionnetNFroguelPet al

Dig Dis Sci (1993) 38:66573.10.1007/BF01316798 6 GutzwillerJPGokeBDreweJHildebrandPKettererSHandschinDet alGlucagon-like peptide-1: a potent regulator of food intake in humans

therefore, it is critical to address menopausal weight gain and the cardiometabolic changes that occur